Clinical trial
Prospective Monitoring of Neuroplastic Effects in Stroke Rehabilitation: Long-term Recovery Prognosis and Therapy Optimization Via Biomarkers
NCT07919301 is registered in ClinicalTrials.gov with Kutahya Health Sciences University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Monitoring of Neuroplastic Effects in Stroke Rehabilitation: Long-term Recovery Prognosis and Therapy Optimization Via Biomarkers
- Lead sponsor
- Kutahya Health Sciences University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- February 1, 2028
- Enrollment
- 72 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
stroke, upper extremity paresis
Arms
As registered; 3 arms.
-
Conventional Rehabilitation
Conventional rehabilitation, 45 minutes per session, 5 days per week for 4 weeks (20 sessions): neurodevelopmental approaches, functional upper-limb exercises, task-oriented training, and stretching and strengthening exercises. From week 4 to week 12: standardized home exercise program. Intervention: Conventional rehabilitation program; Home exercise program
-
Low-Dose VR: Conventional Rehabilitation + VR 2 Days/Week
Conventional rehabilitation as in the control arm plus Neuroforma virtual reality training, 30 minutes per session, 2 days per week for 4 weeks (8 sessions). From week 4 to week 12: the same standardized home exercise program. Intervention: Neuroforma virtual reality training; Conventional rehabilitation program; Home exercise program
-
High-Dose VR: Conventional Rehabilitation + VR 5 Days/Week
Conventional rehabilitation as in the control arm plus Neuroforma virtual reality training, 30 minutes per session, 5 days per week for 4 weeks (20 sessions). From week 4 to week 12: the same standardized home exercise program. Intervention: Neuroforma virtual reality training; Conventional rehabilitation program; Home exercise program
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) Motor Score From Baseline to Week 12
Upper-limb motor impairment measured with the motor domain of the FMA-UE (33 items scored 0 to 2; total 0 to 66, higher scores indicate better motor function), administered by an assessor blinded to group allocation. Change = week-12 score minus baseline score.
Lead sponsor's other trials
Kutahya Health Sciences University, most recent start first.
+213 more trials
Similar trials
Same condition (Paresis) and phase, most recent start first.
+337 more trials See the condition page